The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1582
ISSUE1582
October 7, 2019
Advice for Travelers
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Advice for Travelers
October 7, 2019 (Issue: 1582)
Patients who receive pretravel advice can reduce their
risk for many travel-related conditions. Vaccines recommended
for travelers are reviewed in a separate issue.
- Vaccines for travelers. Med Lett Drugs Ther 2018; 60:185.
- NJ Ajami et al. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med 2014; 21:6.
- FDA In Brief: FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuse. September 20, 2019. Accessed September 26, 2019.
- MS Riddle et al. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008; 47:1007.
- MS Riddle et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med 2017; 24(suppl 1):S63.
- R Steffen et al. Traveler's diarrhea: a clinical review. JAMA 2015; 313:71.
- D Jain et al. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg 2005; 99:207.
- DR Tribble et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007; 44:338.
- In brief: More fluoroquinolone warnings. Med Lett Drugs Ther 2018; 60:136.
- MS Riddle et al. Trial evaluating ambulatory therapy of travelers' diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide. Clin Infect Dis 2017; 65:2008.
- Rifamycin (Aemcolo) for treatment of travelers' diarrhea. Med Lett Drugs Ther 2019; 61:39.
- HL DuPont et al. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study. J Travel Med 2014; 21:369.
- KS Hong and JS Kim. Rifaximin for the treatment of acute infectious diarrhea. Therap Adv Gastroenterol 2011; 4:227.
- R Steffen et al. Rifamycin SV-MMX for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. J Travel Med 2018; 25(1).
- P Zanger et al. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis 2013; 13:946.
- Insect repellents. Med Lett Drugs Ther 2019; 61:129.
- E Mirzaian et al. Mosquito-borne illnesses in travelers: a review of risk and prevention. Pharmacotherapy 2010; 30:1031.
- DO Freedman et al. Medical considerations before international travel. N Engl J Med 2016; 375:247.
- HM Staines et al. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother 2018; 73:581.
- PJ van Genderen et al. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected]. J Travel Med 2007; 14:92.
- LC Steinhardt et al. Review: malaria chemoprophylaxis for travelers to Latin America. Am J Trop Med Hyg 2011; 85:1015.
- M Tickell-Painter et al. Mefloquine for preventing malaria during travel to endemic areas. Cochrane Database Syst Rev 2017; 10:CD006491.
- P Schlagenhauf et al. Use of mefloquine in children – a review of dosage, pharmacokinetics and tolerability data. Malar J 2011; 10:292.
- Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2019 September 20 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
- RL Woosley et al. QT drugs list, AZCERT, Inc. Available at www.credibleMeds.org. Accessed September 26, 2019.
- CS Chu and DO Freedman. Tafenoquine and G6Pd: a primer for clinicians. J Travel Med 2019; 26(4).
- Tafenoquine (Arakoda; Krintafel) for malaria. Med Lett Drugs Ther 2019; 61:101.
- E Meltzer et al. Vivax malaria chemoprophylaxis: the role of atovaquone-proguanil compared to other options. Clin Infect Dis 2018; 66:1751.
- P Schlagenhauf et al. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis 2012; 54:e124.
- RC Mayer et al. Safety of atovaquone-proguanil during pregnancy. J Travel Med 2019; 26(4).
- MG Guzman and E Harris. Dengue. Lancet 2015; 385:453.
- MK Kindhauser et al. Zika: the origin and spread of a mosquito-borne virus. Bull World Health Organ 2016; 94:675.
- SC Weaver and M Lecuit. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 2015; 372:1231.
- F Krauer et al. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: systematic review. PLoS Med 2017; 14(1):e1002203.
- MA Mwachui et al. Environmental and behavioural determinants of leptospirosis transmission: a systematic review. PLoS Negl Trop Dis 2015; 9(9):e0003843.
- ND Gundacker et al. Infections associated with adventure travel: a systematic review. Travel Med Infect Dis 2017; 16:3.
- AM Luks et al. Wilderness Medical Society Practice Guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med 2019 Jun 24 (epub).
- EV Low et al. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. BMJ 2012; 345:e6779.
- TE Kelly and PH Hackett. Acetazolamide and sulfonamide allergy: a not so simple story. High Alt Med Biol 2010: 11:319.
- Sulfonamide cross-reactivity. Med Lett Drugs Ther 2019; 61:44.
- J Xiong et al. Efficacy of ibuprofen on prevention of high altitude headache: a systematic review and meta-analysis. PLoS One 2017; 12:e0179788.
- P Burns et al. Altitude sickness prevention with ibuprofen relative to acetazolamide. Am J Med 2019; 132:247.
- M Maggiorini et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145:497.
- E Leshem et al. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness. J Travel Med 2012; 19:308.
- M Izadi et al. Do pregnant women have a higher risk for venous thromboembolism following air travel? Adv Biomed Res 2015; 4:60.
- D Chandra et al. Meta-analysis: travel and risk for venous thromboembolism. Ann Intern Med 2009; 151:180.
- JR Bartholomew and NS Evans. Travel-related venous thromboembolism. Vasc Med 2019; 24:93.
- MJ Clarke et al. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev 2016; 9:CD004002.
- MR Cesarone et al. Venous thrombosis from air travel: the LON- FLIT3 study–prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology 2002; 53:1.
- C Cingi et al. Jetlag related sleep problems and their management: a review. Travel Med Infect Dis 2018; 24:59.
- J Arendt. Approaches to the pharmacological management of jet lag. Drugs 2018; 78:1419.
- V Srinivasan et al. Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. Adv Ther 2010; 27:796.
- AO Jamieson et al. Zolpidem reduces the sleep disturbance of jet lag. Sleep Med 2001; 2:423.
- PC Zee et al. Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep Med 2010; 11:525.
- WP Williams 3rd et al. Comparative review of approved melatonin agonists for the treatment of circadian rhythm sleep-wake disorders. Pharmacotherapy 2016; 36:1028.
- RP Rosenberg et al. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc 2010; 85:630.
- A Spinks and J Wasiak. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2011; (6):CD002851.
- A Koch et al. The neurophysiology and treatment of motion sickness. Dtsch Arztebl Int 2018; 115:687.
- Sunscreens. Med Lett Drugs Ther 2018; 60:129.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Advice for Travelers
Article code: 1582a
Article code: 1582a
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.